Teledyne Microelectronic Technologies to Co-Sponsor Medtech Insight's "Investment In Innovation" Conference
LOS ANGELES - May 17, 2004 - Teledyne Microelectronic Technologies, a Teledyne Technologies Company (NYSE:TDY), with headquarters in Los Angeles, CA has announced its sponsorship of the "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conference in San Francisco.
Teledyne Microelectronic Technologies is a world-renowned provider of microelectronic engineering and manufacturing services, with an emphasis on highly complex, mixed-technology, mixed-signal, miniaturized electronic assemblies. Since 1974 the Medical Product Line has delivered over a million assemblies to a large variety of customers, ranging from the giants of the industry, such as Medtronic, Guidant, and St. Jude Medical, to small start-up companies. The past and current product mix includes cardio-rhythm management devices (pacemakers, defibrillators, LVADs), as well as drug pumps, implantable and external hearing aids, neural stimulators and a variety of sensors. The developed infrastructure and process know-how allow Teledyne to mix and match conventional chip & wire, Chip-on-Board, SMT and high-density flip-chip technologies to achieve maximum functional performance while minimizing the weight and volume of the final assembly. Both Procurement Chain Management and Quality Systems ensure a dock-to-stock qualified, turnkey operation for Class III devices.
A key advantage of Teledyne's Medical Product Line is its ability to leverage the expertise and technology of other product lines within Teledyne. Relevant product lines include Power Electronics and High-Speed Communications. Customers with applications ranging from hermetic power supplies to telemedicine can take advantage of easy access to experts in the field. Co-located Teledyne Lighting and Displays, brings patented solutions to the table for LED based, high-intensity light sources.
High-reliability, Class III devices are fabricated in Teledyne Microelectronic Technologies' Los Angeles facility. The FDA certified facility of Teledyne Electronic Manufacturing Services in Mexico, a Teledyne facility in Scotland as well as a manufacturing partnership in China, are available for manufacturing of Class I and Class II or higher-volume products. Completing Teledyne's corporate strategy in the field of medical devices is Teledyne Analytical Instruments with its unique line of clinical oxygen analyzers and bio-signal amplifiers. Together, these Teledyne companies are ready to answer the technological demands of the exciting medical device industry. The Medical Devices Group is uniquely positioned for growth through superior technology and customer service.
Medtech Insight's "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conferences are considered the premier forum for senior executives in the medical technology and investment community to preview emerging medtech companies in need of funding, acquisition and/or strategic partnership. In addition to conferences, Medtech Insight publishes the "medtech insight" newsletter, a monthly publication covering the latest trends and innovations in the medical technology industry, analyses of medtech markets through its Reports group, and offers custom consulting and market research. To register for the San Francisco conference or for more information on Medtech Insight, please call Scott Pantel at (949) 219-0150 or (888) 290-2225 toll-free in the U.S., e-mail firstname.lastname@example.org, or visit http://www.medtechinsight.com/in3-11.html.